Morgan Stanley’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-74,524
| Closed | -$10.4M | – | 6866 |
|
|
2018
Q4 | $10.4M | Sell |
74,524
-13,489
| -15% | -$1.89M | ﹤0.01% | 2079 |
|
|
2018
Q3 | $15M | Sell |
88,013
-44,394
| -34% | -$7.58M | ﹤0.01% | 1960 |
|
|
2018
Q2 | $23M | Buy |
132,407
+58,879
| +80% | +$10.2M | 0.01% | 1513 |
|
|
2018
Q1 | $8.48M | Buy |
73,528
+936
| +1% | +$108K | ﹤0.01% | 2500 |
|
|
2017
Q4 | $6.11M | Buy |
72,592
+14,985
| +26% | +$1.26M | ﹤0.01% | 2884 |
|
|
2017
Q3 | $5.31M | Sell |
57,607
-29,587
| -34% | -$2.73M | ﹤0.01% | 2905 |
|
|
2017
Q2 | $6.99M | Buy |
87,194
+55,869
| +178% | +$4.48M | ﹤0.01% | 2513 |
|
|
2017
Q1 | $1.32M | Sell |
31,325
-13,028
| -29% | -$548K | ﹤0.01% | 4173 |
|
|
2016
Q4 | $1.42M | Buy |
44,353
+38,406
| +646% | +$1.23M | ﹤0.01% | 4196 |
|
|
2016
Q3 | $155K | Buy |
5,947
+379
| +7% | +$9.88K | ﹤0.01% | 5117 |
|
|
2016
Q2 | $130K | Buy |
5,568
+3,752
| +207% | +$87.6K | ﹤0.01% | 5125 |
|
|
2016
Q1 | $49K | Sell |
1,816
-14,861
| -89% | -$401K | ﹤0.01% | 5618 |
|
|
2015
Q4 | $475K | Buy |
16,677
+16,324
| +4,624% | +$465K | ﹤0.01% | 4579 |
|
|
2015
Q3 | $6K | Buy |
353
+67
| +23% | +$1.14K | ﹤0.01% | 6360 |
|
|
2015
Q2 | $6K | Sell |
286
-3,809
| -93% | -$79.9K | ﹤0.01% | 6404 |
|
|
2015
Q1 | $51K | Buy |
4,095
+3,593
| +716% | +$44.7K | ﹤0.01% | 5788 |
|
|
2014
Q4 | $6K | Sell |
502
-5,129
| -91% | -$61.3K | ﹤0.01% | 6311 |
|
|
2014
Q3 | $74K | Buy |
+5,631
| New | +$74K | ﹤0.01% | 5594 |
|